Answers are grounded in this paper and cite their sources.
Objectives : The aim of this study was identification of the anti-oxidative and anti-inflammatory effects of Talmyung-san (TMS) in mouse macrophage, RAW264.7 cells. Methods : To identify the anti-oxidative effect of TMS, scavenging activities of DPPH radical, nitric oxide and peroxynitrite were measured in vitro. In RAW264.7 cells, DCFH-DA assay was conducted to examine the inhibitory effect of TMS on ROS production in response to lipopolysaccharide. And the productions of nitric oxide (NO), PGE₂ and pro-inflammatory cytokines were measured. The levels of COX-2, iNOS, nuclear NF- κB p65 expression and phosphorylation of IκB-α in cytosol were detected by western blotting analyses. Results : TMS couldn't scavenged DPPH radical, but nitric oxide and peroxynitrite were decreased. TMS decreased intracellular ROS, NO, and IL- 1β production effectively. However, TMS inhibited PGE₂ levels only in high concentration ( 300μg/m ) and TMS failed to suppress the production of IL-6 and TNF- α . Results from immunoblot analyses revealed that TMS decreased activation of COX-2, iNOS, phosphorylation of IκB-α and nuclear translocation of p65. Conclusions : TMS has anti-RNS and anti-inflammatory effects via NF- κB pathway and more intensive studies will be required to evaluate therapeutic potential of TMS.
No takes yet. Share an insight, caveat, or question.
Jo et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: